THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
Acute myocardial infarction (AMI) is the leading cause of mortality in the most countries, including the Russian Federation. AMI is caused by rupture or erosion of atherosclerotic plaque, followed by occlusive coronary thrombosis. Thrombolytic therapy (TLT) is one of the most widely used and accessi...
Main Authors: | G. P. Ishmurzin, A. A. Podolskaya, A. V. Bondarev A.V |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2010-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1516 |
Similar Items
-
THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01) -
Thrombolytic therapy in acute myocardial infarction at prehospital stage
by: A P Golikov, et al.
Published: (2004-01-01) -
Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01) -
The Efficacy of Thrombolytic Therapy in Inferior Myocardial Infarction with Damage to the Right Ventricular
by: E. S. Mazur, et al.
Published: (2021-05-01) -
Intravenous thrombolytic therapy in myocardial infarction (review)
by: I I Staroverov
Published: (2003-10-01)